Globus Medical Inc: (NYSE: GMED)
$15.72
-0.16 (-1.01%)
Volume 302,528
Jun 18 04:05 PM ET
Zacks Rank: 2-Buy 
| #2 |
Overview Quote
Stock Activity
| Day Low - High | 15.62 - 15.88 |
| 52wk Low - High | 10.26 - 19.93 |
| Previous Close | 15.88 |
| Avg. Volume | 353,468 |
| Industry | MED INSTRUMENTS |
| Market Cap | 1.03 B |
| Div - Yield | 0.00 - 0.00 |
| Beta | 0.11 |
| P/E (F1) | 18.91 |
| Current Year Est. | 0.84 |
| Quarterly Earnings ESP |
NA |
Premium research
Zacks Rank
|
2 |
Zacks Recommendation
|
Neutral |
Zacks Industry Rank
|
178 out of 265 |
Equity Research Report
|
PREMIUM |
( = Change in last 30 days)
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium Start Free Trial
Key Earnings Data
| P/E (F1) | 18.91 |
| PEG Ratio | 1.31 |
| Current Year Est. | 0.84 |
| Current Quarter Estimate | 0.20 |
| Most Accurate Estimate | NA |
| Earnings ESP |
NA |
| Next Earnings Report Date | 08-20-2013 |
| EPS Last Year | 0.82 |
| Expected Earnings Growth | 14.40% |
Company Description
Globus Medical, Inc. is a medical device company focused on the design, development and commercialization of products that promote healing in patients with spine disorders. The Company's products fall into one of two categories: innovative fusion or disruptive technologies. Its innovative fusion products address a broad range of spinal fusion surgical procedures. Its disruptive technology products include minimally invasive surgical, motion preservation and advanced biomaterials technologies. Globus Medical, Inc. is based in Audubon, Pennsylvania.
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Turn Earnings Surprises into quick profits.
Earnings Estimates
| Current Qtr (06/2013) |
Next Qtr (09/2013) |
Current Year (12/2013) |
Next Year (12/2014) |
|
|---|---|---|---|---|
| Average Estimate | 0.20 | 0.20 | 0.84 | 0.93 |
| Number of Estimates | 5 | 4 | 6 | 5 |
| Low Estimate | 0.19 | 0.19 | 0.81 | 0.88 |
| High Estimate | 0.21 | 0.20 | 0.88 | NA |
| Year Ago EPS | 0.21 | 0.18 | 0.80 | 0.84 |
| EPS Growth | -3.81% | 8.33% | 5.00% | 11.19% |
Industry Analysis
| Name | Symbol | Previous Close | Zacks Rank | Zacks Recommendation |
|---|---|---|---|---|
| GLOBUS MEDICAL | GMED | 15.88 | |
|
| NATUS MEDICAL | BABY | 14.08 | |
|
| CRYOLIFE INC | CRY | 6.08 | |
|
| DELCATH SYS INC | DCTH | 0.49 | |
|
| HEARTWARE INTL | HTWR | 92.61 | |
|
| MELA SCIENCES | MELA | 0.85 | |
|
| OXYSURE SYSTEMS | OXYS | 0.79 | |
|
| SUNSHINE HEART | SSH | 5.74 | |
|
| ABIOMED INC | ABMD | 21.74 | |
|
| ALR TECH INC | ALRT | 0.04 | |
|
Sector:Medical>> Industry:MED INSTRUMENTS
COMPARE TICKER vs. Its Peers
Zacks Commentary
Zacks Sell List Highlights: J.C. Penney, LifePoint Hospitals, Globus Medical and Mead Johnson Nutrition
Dec 28, 2012
Bearish MACD for Globus Medical Inc.
Dec 26, 2012
Bearish MACD for Globus Medical Inc.
Dec 11, 2012
Report for GMED
Jun 04, 2013
Financials
| EPS TTM | 0.82 |
| Sales | 386 |
| Net Income | 76 |
| Price/Earnings | 19.37 |
| Price/Book | 3.57 |
| Price/Cash Flow | 11.01 |
| Price/Sales | 2.59 |
News
Canaccord Genuity Reiterates Buy Rating on Globus Medical Following Synthes Legal Verdict - Benzinga
Jun 17, 2013
Globus Medical Announces Jury Verdict in Patent Infringement Lawsuit - Businesswire
Jun 17, 2013
UPDATE: Piper Jaffray Reiterates Overweight on Globus Medical on Synthes Award in Line With Expectations - Benzinga
Jun 17, 2013
The 5 Best Medical Device Stocks of 2013 - TheMotleyFool
Jun 15, 2013
DePuy, Inc. Market Share Analysis Report - M2
Jun 10, 2013
Globus Medical to Present at Upcoming Investor Events - Close-Up Media
Jun 10, 2013
Medtronic, Inc. Market Share Analysis Report - M2
Jun 10, 2013
Globus Medical to Participate at Investor Events in June - Businesswire
Jun 4, 2013
Broker Recommendations
| Current ABR | 1.00 |
| ABR (Last Week) | 1.00 |
| # of recs in ABR | 6 |
| Average Target Price | 20.20 |
| Industry Rank by ABR | 178 out of 265 |
| Rank in Industry | 2 out of 54 |
